Compounds > benzoylamido-4--aminostilbene-2-2--disulfonate

benzoylamido-4--aminostilbene-2-2--disulfonate and Hodgkin-Disease

benzoylamido-4--aminostilbene-2-2--disulfonate has been researched along with Hodgkin-Disease* in 1 studies

Other Studies

1 other study(ies) available for benzoylamido-4--aminostilbene-2-2--disulfonate and Hodgkin-Disease

Article	Year
Hematology. Are macrophages the bad guys in Hodgkin lymphoma? Nature reviews. Clinical oncology, 2010, Volume: 7, Issue:6 Prognostic models for patients with Hodgkin lymphoma are imperfect and do not allow a precise individualized therapy. A recent gene-expression profiling study, translated into a routine immunohistological test, identified genes of tumor-associated macrophages as being responsible for treatment outcome in patients with Hodgkin lymphoma. If this finding is confirmed by other investigators, it could be a major step towards personalized therapy for patients with Hodgkin lymphoma. Topics: Clinical Laboratory Techniques; Gene Expression Profiling; Hematologic Tests; Hodgkin Disease; Humans; Macrophages; Microarray Analysis; Prognosis; Stilbenes; Treatment Outcome	2010

Article

Year

Hematology. Are macrophages the bad guys in Hodgkin lymphoma?

Nature reviews. Clinical oncology, 2010, Volume: 7, Issue:6

Prognostic models for patients with Hodgkin lymphoma are imperfect and do not allow a precise individualized therapy. A recent gene-expression profiling study, translated into a routine immunohistological test, identified genes of tumor-associated macrophages as being responsible for treatment outcome in patients with Hodgkin lymphoma. If this finding is confirmed by other investigators, it could be a major step towards personalized therapy for patients with Hodgkin lymphoma.

Topics: Clinical Laboratory Techniques; Gene Expression Profiling; Hematologic Tests; Hodgkin Disease; Humans; Macrophages; Microarray Analysis; Prognosis; Stilbenes; Treatment Outcome

2010